Dialysis modality is independently associated with circulating endothelial progenitor cells in end-stage renal disease patients

Nephrology Dialysis Transplantation

Volumn 25, Issue 2, 2010, Pages 581-586

  Ueno, Hiroki ^a   Koyama, Hidenori ^a   Fukumoto, Shinya ^a   Tanaka, Shinji ^a   Shoji, Takuhito ^a   Shoji, Tetsuo ^a   Emoto, Masanori ^a   Tahara, Hideki ^a   Tsujimoto, Yoshihiro ^b   Tabata, Tsutomu ^b   Nishizawa, Yoshiki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Inoue Hospital   (Japan)

Author keywords

Arteriosclerosis; Diabetes mellitus; Endothelial cells; Haemodialysis; Peritoneal dialysis

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; ARTERIOLOSCLEROSIS; ARTERY COMPLIANCE; ARTICLE; CELL COUNT; COLONY FORMING UNIT; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; ENDOTHELIUM STEM CELL; FEMALE; FLOW CYTOMETRY; HEMODIALYSIS; HUMAN; HUMAN CELL; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULSE WAVE; STEM CELL;

ENDOTHELIAL CELLS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; RENAL DIALYSIS; STEM CELLS;

EID: 75649136220     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp358     Document Type: Article

References (36)

1. Asahara T, Murohara T, Sullivan A et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-967
2. Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003; 9: 702-712
3. Rauscher FM, Goldschmidt-Clermont PJ, Davis BH et al. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 2003; 108: 457-463
4. Gill M, Dias S, Hattori K et al. Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circ Res 2001; 88: 167-174
5. Shintani S, Murohara T, Ikeda H et al.Mobilizationofendothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001; 103: 2776-2779
6. Takahashi T, Kalka C, Masuda H et al. Ischemia-and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999; 5: 434-438 (Pubitemid 29180584)
7. Hill JM, Zalos G, Halcox JP et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593-600
8. Schmidt-Lucke C, Rossig L, Fichtlscherer S et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005; 111: 2981-2987
9. Werner N, Kosiol S, Schiegl T et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005; 353: 999-1007 (Pubitemid 41262334)
10. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305
11. Haffner SM, Lehto S, Ronnemaa T et al.Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229-234
12. Choi JH, Kim KL, Huh W et al. Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler Thromb Vasc Biol 2004; 24: 1246-1252
13. de Groot K, Bahlmann FH, Sowa J et al. Uremia causes endothelial progenitor cell deficiency. Kidney Int 2004; 66: 641-646
14. Herbrig K, Pistrosch F, Oelschlaegel U et al. Increased total number but impaired migratory activity and adhesion of endothelial progenitor cells in patients on long-term hemodialysis. Am J Kidney Dis 2004; 44: 840-849
15. Schlieper G, Hristov M, Brandenburg V et al. Predictors of low circulating endothelial progenitor cell numbers in haemodialysis patients. Nephrol Dial Transplant 2008; 23: 2611-2618
16. Steiner S, Schaller G, Puttinger H et al. History of cardiovascular disease is associated with endothelial progenitor cells in peritoneal dialysis patients. Am J Kidney Dis 2005; 46: 520-528 (Pubitemid 41208189)
17. Kondo T, Hayashi M, Takeshita K et al. Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers. Arterioscler Thromb Vasc Biol 2004; 24: 1442-1447
18. Werner C, Kamani CH, Gensch C et al. The peroxisome proliferator- activated receptor-gamma agonist pioglitazone increases number and functionofendothelial progenitor cellsinpatients with coronaryartery disease and normal glucose tolerance. Diabetes 2007; 56: 2609-2615
19. Ueno H, Koyama H, Tanaka S et al. Skin autofluorescence, a marker for advanced glycation end product accumulation, is associated with arterial stiffness in patients with end-stage renal disease. Metabolism 2008; 57: 1452-1457
20. Yamashina A, Tomiyama H, Takeda K et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002; 25: 359-364
21. Bahlmann FH, de Groot K, Mueller O et al. Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists. Hypertension 2005; 45: 526-529
22. Dimmeler S, Aicher A, Vasa M et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 2001; 108: 391-397
23. Llevadot J, Murasawa S, Kureishi Y et al. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J Clin Invest 2001; 108: 399-405
24. Vasa M, Fichtlscherer S, Aicher A et al.Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001; 89: E1-E7
25. Peichev M, Naiyer AJ, Pereira D et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000; 95: 952-958
26. Chan CT, Li SH, Verma S. Nocturnal hemodialysis is associated with restorationofimpaired endothelial progenitor cell biologyinend-stage renal disease. Am J Physiol Renal Physiol 2005; 289: F679-F684
27. Cross JM, Donald A, Vallance PJ et al. Dialysis improves endothelial function in humans. Nephrol Dial Transplant 2001; 16: 1823-1829
28. Kocak H, Ceken K, Dinckan A et al. Assessment and comparison of endothelial function between dialysis and kidney transplant patients. Transplant Proc 2006; 38: 416-418
29. Ramirez R, Martin-Malo A, Aljama P. Inflammation and hemodiafil-tration. Contrib Nephrol 2007; 158: 210-215
30. Miyata T, Ueda Y, Yoshida A et al. Clearance of pentosidine, an advanced glycation end product, by different modalities of renal replacement therapy. Kidney Int 1997; 51: 880-887
31. Ueno H, Koyama H, Fukumoto S et al. Skin accumulaiton of advanced glycation end-products is inversely associated with number of endothelial progenitor cells in subjects with end-stage renal diseases. Diabetes 2008; 57(Suppl 1): A624
32. Fadini GP, Coracina A,BaessoI et al. Peripheral blood CD34+KDR+ endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population. Stroke 2006; 37: 2277-2282
33. Blacher J, Guerin AP, Pannier B et al. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999; 99: 2434-2439
34. Kitahara T, Ono K, Tsuchida A et al. Impact of brachial-ankle pulse wave velocity and ankle-brachial blood pressure index on mortality in hemodialysis patients. Am J Kidney Dis 2005; 46: 688-696
35. Shoji T, Emoto M, Shinohara K et al. Diabetes mellitus, aortic stiffness, and cardiovascular mortality in end-stage renal disease. J Am Soc Nephrol 2001; 12: 2117-2124
36. Heeschen C, Aicher A, Lehmann R et al. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 2003; 102: 1340-1346